POM-V Prescription Required

Rhinovac IBR Marker live Lyophilisate and Solvent for Suspension for Injection or Nasal Spray for Cattle

Active ingredient: Infectious bovine rhinotraceitis virus

Form

Injection

Species

Cattle

Manufacturer

Animal Health Distributors Limited

VMD MA No.

51609/4002

What it's used for

For the active immunisation of cattle to reduce the severity and duration of clinical signs and viral excretion caused by BHV-1 (infectious bovine rhinotra...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Infectious bovine rhinotrace...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Rhinovac IBR Marker live Lyophilisate and Solvent for Suspension for Injection or Nasal Spray for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For the active immunisation of cattle to reduce the severity and duration of
clinical signs and viral excretion caused by BHV-1 (infectious bovine
rhinotracheitis; IBR) infections.
Onset of Immunity:
One week after intranasal vaccination of calves from 2 weeks of age without
maternally derived antibodies

Issued: September 2021
AN: 00760/2020
Two weeks after intramuscular vaccination of calves from 3 months of age.
Duration of immunity:
Ten weeks after intranasal vaccination of calves from 2 weeks of age without
maternally derived antibodies
Six months after intramuscular vaccination of calves from 3 months of age.

None

A transient slight increase in rectal temperature very commonly occurs
(increase of 0.4°C following intramuscular administration and increase of 1.0°C
following intranasal administration) which resolves within 4 days.
The frequency of adverse reactions is defined using the following convention:
Very common (more than 1 in 10 animals treated displaying adverse reactions)
Common (more than 1 but less than 10 animals in 100 animals treated)
Uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
Rare (more than 1 but less than 10 animals in 10,000 animals treated)

Issued: September 2021
AN: 00760/2020
Very rare (less than 1 animal in 10,000 animals treated, including isolated
reports)

Maternal antibodies have been shown to have a negative impact on the efficacy
of intranasal vaccination of calves from 2 weeks of age, therefore the efficacy of
intranasal vaccination has been demonstrated only in seronegative calves. The
presence of maternally derived antibodies in calves from 3 months of age do
not interfere with the response to intramuscular vaccination.
Vaccinate healthy animals only.

Special precautions for use in animals
Following intranasal vaccination, vaccinated animals may shed the vaccine
strain by the nasal route for up to 5 days. While this did not result in spread of
the vaccine strain to unvaccinated animals that were in contact with vaccinated
animals, the risk of spread cannot be fully excluded and therefore appropriate
precautions should be taken to avoid spread if considered necessary.
Special precautions for the person administering the veterinary medicinal
product to animals
In case of adverse reactions following accidental self-injection or accidental
exposure to aerosols, seek medical advice immediately and show the package
leaflet or label to the physician.

interaction
No information is available on the safety and efficacy of this vaccine when used
with any other veterinary medicinal product. A decision to use this vaccine
before or after any other veterinary medicinal product needs to be made on a
case-by-case basis.

Store in a refrigerator (2
°
C - 8
°
C)
Protect from light
Store the reconstituted vaccine below 25
°
C (for up to 8 hours) and do not
freeze.

– 10
7.5
TCID50
*
*TCID50 – medium tissue culture infectious dose (50%)
Excipients:
For the full list of excipients see

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.